Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer

Clinical trial NCT00593827 · COMPLETED

Trial details

NCT number: NCT00593827
Sponsor: R-Pharm
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2008-05-01
Primary completion: 2010-08-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.